Aurora Cannabis Inc (NASDAQ:ACB) traded at $6.32 at close of the session on Monday, April 29, made a downward move of -5.67% on its previous day’s price.
Looking at the stock we see that its previous close was $6.70. The company has a trailing 12-month PE ratio of 0.70. In terms of its 52-week price range, ACB has a high of $11.50 and a low of $2.84. The company’s stock has gained about 43.96% over that past 30 days.
Aurora Cannabis Inc has a market cap of $99.41 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.17, with the EPS growth for the year raised at -$0.92 for 2024 and -$0.31 for next year.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $51.23 million, with a low of $50.42 million and a high of $53.22 million. The median projection represents growth squeezing down to 9.30% compared to sales growth for the corresponding quarter a year ago.
On the other hand, looking at the outlook for the ACB stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 25% Buy. Long term indicators on average place the stock in the category of 50% Buy.
Looking further, we note the current price level is -2.05% off its SMA20 and 35.14% from its 50-day simple moving average. The RSI (14) is pointing at 53.82 while the volatility over the past week is 12.23% and jumps to 17.34% over the past one month. The beta value is 2.19, while the average true range (ATR) is currently pointing at 0.81.
Coming back to Aurora Cannabis Inc (NASDAQ:ACB), we note that the average 3-month trading volume was 6.10 million. Current shares outstanding are 34.53 million.
The insiders hold 1.50% of the company’s shares while institutions hold 26.29%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 32.72% up in year-to-date price movement.
